These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19406728)

  • 1. Biomarkers and prognosis in malignant lymphomas.
    Hagenbeek A; Gascoyne RD; Dreyling M; Kluin P; Engert A; Salles G
    Clin Lymphoma Myeloma; 2009 Apr; 9(2):160-6. PubMed ID: 19406728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic biomarkers in malignant lymphomas.
    Gascoyne RD; Rosenwald A; Poppema S; Lenz G
    Leuk Lymphoma; 2010 Aug; 51 Suppl 1():11-9. PubMed ID: 20658955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of cyclin D1 (and CD5) detection in the diagnosis of malignant lymphomas other than mantle cell lymphoma].
    Plank L
    Cesk Patol; 2011 Jul; 47(3):96-100. PubMed ID: 21887925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression profile and prognostic significance of CD24, p53 and p21 in lymphomas. A tissue microarray study of over 600 non-Hodgkin lymphomas].
    Went P; Dellas T; Bourgau C; Maurer R; Augustin F; Tzankov A; Dirnhofer S
    Dtsch Med Wochenschr; 2004 Oct; 129(40):2094-9. PubMed ID: 15455300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical approach to the diagnosis of Hodgkin lymphoma.
    Listinsky CM
    Am J Clin Pathol; 2002 Jun; 117 Suppl():S76-94. PubMed ID: 14569804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas.
    O'Malley DP; Auerbach A; Weiss LM
    Arch Pathol Lab Med; 2015 Sep; 139(9):1094-107. PubMed ID: 25554969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
    Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
    Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.
    Jiang M; Bennani NN; Feldman AL
    Expert Rev Hematol; 2017 Mar; 10(3):239-249. PubMed ID: 28133975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma.
    Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T
    Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New trends and novel possibilities in the diagnosis of lymphomas].
    Illés Á; Simon Z
    Magy Onkol; 2015 Mar; 59(1):73-8. PubMed ID: 25763917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.
    Krenács D; Borbényi Z; Bedekovics J; Méhes G; Bagdi E; Krenács L
    Virchows Arch; 2015 Sep; 467(3):345-55. PubMed ID: 26089142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report of an International Network of Cancer Treatment and Research workshop on non-Hodgkin's lymphoma in developing countries.
    Naresh KN; Advani S; Adde M; Aziz Z; Banavali S; Bhatia K; Belgaumi A; Ezzat A; Khaled H; Mokhtar N; Norton A; Rohatiner A; Sagar TG; Taciyliz N; Temmim L; Venkatesh C; Yan Tang J; Magrath I
    Blood Cells Mol Dis; 2004; 33(3):330-7. PubMed ID: 15528153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications.
    Naresh KN; Srinivas V; Soman CS
    Ann Oncol; 2000; 11 Suppl 1():63-7. PubMed ID: 10707782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction. "Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)" (J Clin Pathol 2009;62:128–38;doi:10.1136/jcp.2008.057257).
    J Clin Pathol; 2012 Sep; 65(9):861-2. PubMed ID: 22930798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant lymphomas in children and adolescents. Practical knowledge for diagnosis].
    Oschlies I; Klapper W
    Pathologe; 2014 Jul; 35(4):383-95; quiz 396-7. PubMed ID: 24780951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
    Lynch RC; Gratzinger D; Advani RH
    Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.